Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions

Pediatric Infectious Disease Journal

Volumn 19, Issue 1, 2000, Pages 1-7

  Malley, Richard ^a,b   Vernacchio, Louis ^a,c   Devincenzo, John ^d   Ramilo, Octavio ^e   Dennehy, Penelope H ^f   Meissner, H Cody ^g   Gruber, William C ^h   Jafri, Hasan S ^e   Sanchez, Pablo J ^e   Macdonald, Kristin ^a   Montana, John B ^a   Thompson, Claudette M ^a   Ambrosino, Donna M ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BOSTON UNIVERSITY   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

^f HASBRO CHILDREN'S HOSPITAL   (United States)

^g TUFTS MEDICAL CENTER   (United States)

^h VANDERBILT UNIVERSITY   (United States)

Author keywords

Enzyme linked immunosorbent assay; Respiratory syncytial virus; Tracheal secretions

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; MYELOPEROXIDASE; PALIVIZUMAB;

ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOTRACHEAL INTUBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFANT; LEUKOCYTE COUNT; NOSE SECRETION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TRACHEA MUCUS; VIRUS CONCENTRATION; VIRUS INFECTION;

EID: 0033957265     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200001000-00002     Document Type: Article

References (16)

1. American Academy of Pediatrics Committee on Infectious Diseases. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections [see comments]. Pediatrics 1996;97:137-40.
2. Groothuis JR, Simoes EA, Levin MJ, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children: The Respiratory Syncytial Virus Immune Globulin Study Group [see comments]. N Engl J Med 1993;329:1524-30.
3. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-7.
4. Hemming VG, Rodriguez W, Kim HW, et al. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother 1987;31:1882-6.
5. Rodriguez WJ, Gruber WC, Groothuis JR, et al. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. Pediatrics 1997;100:937-42.
6. Rodriguez WJ, Gruber WC, Welliver RC, et al. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group [see comments]. Pediatrics 1997;99:454-61.
7. Graham BS, Perkins MD, Wright PF, Karzon DT. Primary respiratory syncytial virus infection in mice. J Med Virol 1988;26:153-62.
8. Malley R, DeVincenzo J, Ramilo O, et al. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis 1998;178:1555-61.
9. Arnold R, Werner F, Humbert B, Werchau H, Konig W. Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes. Immunology 1994;82:184-91.
10. Arnold R, Humbert B, Werchau H, Gallati H, Konig W. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 1994;82:126-33.
11. Arnold R, Konig B, Galatti H, Werchau H, Konig W. Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection. Immunology 1995;85:364-72.
12. Becker S, Reed W, Henderson FW, Noah TL. RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES. Am J Physiol 1997; 272:L512-20.
13. Sheeran P, Jafri H, Carubelli C, et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999;18:115-22.
14. Chao RK, Fishaut M, Schwartzman JD, McIntosh K. Detection of respiratory syncytial virus in nasal secretions from infants by enzyme-linked immunosorbent assay. J Infect Dis 1979;139:483-6.
15. Hendry RM, McIntosh K. Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: development and description. J Clin Microbiol 1982;16: 324-8.
16. McIntosh K, Hendry RM, Fahnestock ML, Pierik LT. Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples. J Clin Microbiol 1982;16:329-33.